L
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Netherlands
Recent Filings
- 8-K199.4 KBLAVA Therapeutics NVNov 21, 8:00 AM ET·0001104659-25-114793
- 8-K247.9 KBLAVA Therapeutics NVNov 13, 8:40 AM ET·0001104659-25-110913
- 6-K1.5 MBLAVA Therapeutics NVDec 10, 4:05 PM ET·0001558370-24-016119
- 6-K26.6 KBLAVA Therapeutics NVJun 20, 4:10 PM ET·0001558370-24-009357
- 6-K5.8 MBLAVA Therapeutics NVJun 6, 4:05 PM ET·0001558370-24-008952
- 6-K983.1 KBLAVA Therapeutics NVMay 21, 4:05 PM ET·0001558370-24-008534
- 6-K278.5 KBLAVA Therapeutics NVMar 21, 7:05 AM ET·0001558370-24-003667
- SC 13D/A62.1 KBLAVA Therapeutics NVMar 7, 7:09 PM ET·0001193125-24-062515
- SC 13G/A89.0 KBLAVA Therapeutics NVFeb 14, 4:26 PM ET·0001104659-24-023773
- 6-K8.5 MBLAVA Therapeutics NVApr 24, 4:05 PM ET·0001558370-23-006521
Insiders
0No insiders on record
Tickers
No tickers on record
Addresses
business
YALELAAN 62
UTRECHT
mailing
YALELAAN 62
UTRECHT
Former Names
- LAVA Therapeutics BV2021-03-24